The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
KRAS Tests-Global Market Insights and Sales Trends 2024
Synopsis
Kirsten Rat Sarcoma(KRAS)is a downstream signalling molecule in the EGFR cellular pathway with roles in cell growth and proliferation
The global KRAS Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of KRAS Tests in various end use industries. The expanding demands from the Colorectal Cancer (CRC) and Lung Cancer, are propelling KRAS Tests market. KRAS Sanger sequencing Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the KRAS Nucleic Acid Amplification Tests (NAAT) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for KRAS Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the KRAS Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for KRAS Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global KRAS Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global KRAS Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, KRAS Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of KRAS Tests covered in this report include Qiagen NV, F. Hoffmann-La Roche Ltd,, Thermo Fisher Scientific Inc, Takara Bio Inc, Panagene Inc and Amoy Diagnostics Co Ltd, etc.
The global KRAS Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen NV
F. Hoffmann-La Roche Ltd,
Thermo Fisher Scientific Inc
Takara Bio Inc
Panagene Inc
Amoy Diagnostics Co Ltd
Global KRAS Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global KRAS Tests market, Segment by Type:
KRAS Sanger sequencing Tests
KRAS Nucleic Acid Amplification Tests (NAAT)
KRAS Other Tests
Global KRAS Tests market, by Application
Colorectal Cancer (CRC)
Lung Cancer
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of KRAS Tests manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of KRAS Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Kirsten Rat Sarcoma(KRAS)is a downstream signalling molecule in the EGFR cellular pathway with roles in cell growth and proliferation
The global KRAS Tests market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of KRAS Tests in various end use industries. The expanding demands from the Colorectal Cancer (CRC) and Lung Cancer, are propelling KRAS Tests market. KRAS Sanger sequencing Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the KRAS Nucleic Acid Amplification Tests (NAAT) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for KRAS Tests market, driven by demand from China, the second largest economy with some signs of stabilising, the KRAS Tests market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for KRAS Tests, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global KRAS Tests market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global KRAS Tests market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, KRAS Tests sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of KRAS Tests covered in this report include Qiagen NV, F. Hoffmann-La Roche Ltd,, Thermo Fisher Scientific Inc, Takara Bio Inc, Panagene Inc and Amoy Diagnostics Co Ltd, etc.
The global KRAS Tests market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Qiagen NV
F. Hoffmann-La Roche Ltd,
Thermo Fisher Scientific Inc
Takara Bio Inc
Panagene Inc
Amoy Diagnostics Co Ltd
Global KRAS Tests market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global KRAS Tests market, Segment by Type:
KRAS Sanger sequencing Tests
KRAS Nucleic Acid Amplification Tests (NAAT)
KRAS Other Tests
Global KRAS Tests market, by Application
Colorectal Cancer (CRC)
Lung Cancer
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of KRAS Tests manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of KRAS Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 KRAS Tests Market Overview
1.1 KRAS Tests Product Overview
1.2 KRAS Tests Market Segment by Type
1.2.1 KRAS Sanger sequencing Tests
1.2.2 KRAS Nucleic Acid Amplification Tests (NAAT)
1.2.3 KRAS Other Tests
1.3 Global KRAS Tests Market Size by Type
1.3.1 Global KRAS Tests Market Size Overview by Type (2018-2029)
1.3.2 Global KRAS Tests Historic Market Size Review by Type (2018-2023)
1.3.3 Global KRAS Tests Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America KRAS Tests Sales Breakdown by Type (2018-2023)
1.4.2 Europe KRAS Tests Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific KRAS Tests Sales Breakdown by Type (2018-2023)
1.4.4 Latin America KRAS Tests Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa KRAS Tests Sales Breakdown by Type (2018-2023)
2 Global KRAS Tests Market Competition by Company
2.1 Global Top Players by KRAS Tests Sales (2018-2023)
2.2 Global Top Players by KRAS Tests Revenue (2018-2023)
2.3 Global Top Players by KRAS Tests Price (2018-2023)
2.4 Global Top Manufacturers KRAS Tests Manufacturing Base Distribution, Sales Area, Product Type
2.5 KRAS Tests Market Competitive Situation and Trends
2.5.1 KRAS Tests Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by KRAS Tests Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in KRAS Tests as of 2022)
2.7 Date of Key Manufacturers Enter into KRAS Tests Market
2.8 Key Manufacturers KRAS Tests Product Offered
2.9 Mergers & Acquisitions, Expansion
3 KRAS Tests Status and Outlook by Region
3.1 Global KRAS Tests Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global KRAS Tests Historic Market Size by Region
3.2.1 Global KRAS Tests Sales in Volume by Region (2018-2023)
3.2.2 Global KRAS Tests Sales in Value by Region (2018-2023)
3.2.3 Global KRAS Tests Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global KRAS Tests Forecasted Market Size by Region
3.3.1 Global KRAS Tests Sales in Volume by Region (2024-2029)
3.3.2 Global KRAS Tests Sales in Value by Region (2024-2029)
3.3.3 Global KRAS Tests Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global KRAS Tests by Application
4.1 KRAS Tests Market Segment by Application
4.1.1 Colorectal Cancer (CRC)
4.1.2 Lung Cancer
4.2 Global KRAS Tests Market Size by Application
4.2.1 Global KRAS Tests Market Size Overview by Application (2018-2029)
4.2.2 Global KRAS Tests Historic Market Size Review by Application (2018-2023)
4.2.3 Global KRAS Tests Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America KRAS Tests Sales Breakdown by Application (2018-2023)
4.3.2 Europe KRAS Tests Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific KRAS Tests Sales Breakdown by Application (2018-2023)
4.3.4 Latin America KRAS Tests Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa KRAS Tests Sales Breakdown by Application (2018-2023)
5 North America KRAS Tests by Country
5.1 North America KRAS Tests Historic Market Size by Country
5.1.1 North America KRAS Tests Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America KRAS Tests Sales in Volume by Country (2018-2023)
5.1.3 North America KRAS Tests Sales in Value by Country (2018-2023)
5.2 North America KRAS Tests Forecasted Market Size by Country
5.2.1 North America KRAS Tests Sales in Volume by Country (2024-2029)
5.2.2 North America KRAS Tests Sales in Value by Country (2024-2029)
6 Europe KRAS Tests by Country
6.1 Europe KRAS Tests Historic Market Size by Country
6.1.1 Europe KRAS Tests Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe KRAS Tests Sales in Volume by Country (2018-2023)
6.1.3 Europe KRAS Tests Sales in Value by Country (2018-2023)
6.2 Europe KRAS Tests Forecasted Market Size by Country
6.2.1 Europe KRAS Tests Sales in Volume by Country (2024-2029)
6.2.2 Europe KRAS Tests Sales in Value by Country (2024-2029)
7 Asia-Pacific KRAS Tests by Region
7.1 Asia-Pacific KRAS Tests Historic Market Size by Region
7.1.1 Asia-Pacific KRAS Tests Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific KRAS Tests Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific KRAS Tests Sales in Value by Region (2018-2023)
7.2 Asia-Pacific KRAS Tests Forecasted Market Size by Region
7.2.1 Asia-Pacific KRAS Tests Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific KRAS Tests Sales in Value by Region (2024-2029)
8 Latin America KRAS Tests by Country
8.1 Latin America KRAS Tests Historic Market Size by Country
8.1.1 Latin America KRAS Tests Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America KRAS Tests Sales in Volume by Country (2018-2023)
8.1.3 Latin America KRAS Tests Sales in Value by Country (2018-2023)
8.2 Latin America KRAS Tests Forecasted Market Size by Country
8.2.1 Latin America KRAS Tests Sales in Volume by Country (2024-2029)
8.2.2 Latin America KRAS Tests Sales in Value by Country (2024-2029)
9 Middle East and Africa KRAS Tests by Country
9.1 Middle East and Africa KRAS Tests Historic Market Size by Country
9.1.1 Middle East and Africa KRAS Tests Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa KRAS Tests Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa KRAS Tests Sales in Value by Country (2018-2023)
9.2 Middle East and Africa KRAS Tests Forecasted Market Size by Country
9.2.1 Middle East and Africa KRAS Tests Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa KRAS Tests Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Qiagen NV
10.1.1 Qiagen NV Company Information
10.1.2 Qiagen NV Introduction and Business Overview
10.1.3 Qiagen NV KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Qiagen NV KRAS Tests Products Offered
10.1.5 Qiagen NV Recent Development
10.2 F. Hoffmann-La Roche Ltd,
10.2.1 F. Hoffmann-La Roche Ltd, Company Information
10.2.2 F. Hoffmann-La Roche Ltd, Introduction and Business Overview
10.2.3 F. Hoffmann-La Roche Ltd, KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.2.4 F. Hoffmann-La Roche Ltd, KRAS Tests Products Offered
10.2.5 F. Hoffmann-La Roche Ltd, Recent Development
10.3 Thermo Fisher Scientific Inc
10.3.1 Thermo Fisher Scientific Inc Company Information
10.3.2 Thermo Fisher Scientific Inc Introduction and Business Overview
10.3.3 Thermo Fisher Scientific Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Thermo Fisher Scientific Inc KRAS Tests Products Offered
10.3.5 Thermo Fisher Scientific Inc Recent Development
10.4 Takara Bio Inc
10.4.1 Takara Bio Inc Company Information
10.4.2 Takara Bio Inc Introduction and Business Overview
10.4.3 Takara Bio Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Takara Bio Inc KRAS Tests Products Offered
10.4.5 Takara Bio Inc Recent Development
10.5 Panagene Inc
10.5.1 Panagene Inc Company Information
10.5.2 Panagene Inc Introduction and Business Overview
10.5.3 Panagene Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Panagene Inc KRAS Tests Products Offered
10.5.5 Panagene Inc Recent Development
10.6 Amoy Diagnostics Co Ltd
10.6.1 Amoy Diagnostics Co Ltd Company Information
10.6.2 Amoy Diagnostics Co Ltd Introduction and Business Overview
10.6.3 Amoy Diagnostics Co Ltd KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amoy Diagnostics Co Ltd KRAS Tests Products Offered
10.6.5 Amoy Diagnostics Co Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 KRAS Tests Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 KRAS Tests Industrial Chain Analysis
11.4 KRAS Tests Market Dynamics
11.4.1 KRAS Tests Industry Trends
11.4.2 KRAS Tests Market Drivers
11.4.3 KRAS Tests Market Challenges
11.4.4 KRAS Tests Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 KRAS Tests Distributors
12.3 KRAS Tests Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
